Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults
- 544 Downloads
To study the occurrence of relapse of herpes simplex encephalitis (HSE) and to find out whether soluble activity markers in cerebrospinal fluid (CSF) indicate direct viral or immune– mediated events.
A consecutive series of 32 adult survivors of HSE were followed to determine the incidence of clinical relapse of HSE. Four patients had neurological deterioration interpreted as relapsing HSE. Four non–relapsing HSE cases were selected as matched controls. Fiftynine batched, paired CSF and serum samples from the eight HSE patients were analysed for soluble activity markers, predominantly cytokines and mediators (interferon– γ, soluble CD8, tumour necrosis factor–α, and interleukin–10), amount of HSV–DNA and markers of glial and neuronal destruction (neurofilament protein, glial fibrillary acidic protein, S–100–β, and neuron specific enolase).
Relapse of HSE was diagnosed in 3 of 26 (12 %) acyclovir–treated patients (5 episodes during 6.1 years of followup) and in 1 of 6 vidarabine–recipients. All relapses occurred from 1 to 4 months after acute HSE, except for a second relapse after 3.3 years in one patient. Computer tomography at relapses revealed few abnormalities apart from those found during the primary disease. Intravenous acyclovir and corticosteroids were given for 7–21 days in all the relapse patients. All relapse patients seemed to recover to the pre–relapse condition. HSV–DNA was demonstrated in CSF in all patients during the acute stage but not in any of 13 CSF samples taken during relapse phases. The HSV viral load during the acute stage of HSE was not higher or of longer duration in the relapsing patients than in the non–relapsing HSE controls. The levels of sCD8 were increased in nearly all CSF samples tested with peaks of sCD8 at one month of acute HSE. In all episodes of relapse, sCD8 peaks were detected during the first week at high levels. CSF levels of neuron–specific enolase, S–100 and glial fibrillary acidic protein were markedly lower at relapse than at the acute stage of HSV–1 encephalitis.
The lack of demonstrable HSV DNA in CSF, the lack of acute CSF signs and the lack of signs of neural and glia cells destruction indicate that a direct viral cytotoxicity is not the major pathogenic mechanism in relapse. Instead, the pronounced CSF proinflammatory immunological response and the relative lack of CSF anti–inflammatory cytokine IL–10 response suggest immunologically–mediated pathogenicity.
Key wordsrelapse of herpes simplex encephalitis cerebrospinal fluid HSV–DNA soluble CD8 and interleukin–10 neurofilament protein
Unable to display preview. Download preview PDF.
- 1.Sköldenberg B, Forsgren M, Alestig K, Bergström T, et al. (1984) Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet ii:707–711Google Scholar
- 7.Abramson JS, Roach SE, Levy HB (1984) Post–infectious encephalopathy after treatment of herpes simplex encephalitis with acyclovir. Ped Infect Dis 3:146–147Google Scholar
- 8.Wang HS, Kuo MF, Huang SC, Chou ML (1994) Choreoathetosis as an initial sign of relapsing of herpes simplex encephalitis. Pediatric Neurol 11:341–344Google Scholar
- 11.Aurelius A, Andersson A, Forsgren M, Sköldenberg B, Strannegård Ö (1994) Cytokine and other markers of intrathecal immune response in patients with herpes simplex encephalitis. J Inf Dis 170:678–681Google Scholar
- 12.Aurelius A, Forsgren M, Sköldenberg B, Strannegård Ö (1993) Persistent intrathecal immune activation in patients with herpes simplex encephalitis. J Inf Dis 168:1248–1252Google Scholar
- 14.Günther G, Haglund M, Lindquist L, Forsgren M, Sköldenberg B (1996) Intrathecal production of neopterin and β–2 microglobulin in Tick–borne encephalitis (TBE) compared to meningo–encephalitis of other etiology. Scand J Inf Dis 28:131–138Google Scholar
- 22.Aurelius E, Forsgren M, Skoog E, Sköldenberg B (1989) Serodiagnosis of herpes simplex encephalitis by antibody capture enzyme–linked immunosorbent assay. Serodiagn Immunother Infect Dis 3:249–258Google Scholar
- 24.Hjalmarsson A, Aurelius E, Glimåker M, Hart J, Kraut M, Sköldenberg B (2005) Contralateral, subacute relapse of herpes simplex encephalitis with severe sequels. In manuscriptGoogle Scholar
- 28.Yamada S, Kameyama T, Nagaya S, Hashizume Y, Yoshida M (2003) Relapsing herpes simplex encephalitis: pathological confirmation of viral reactivation. J Neurol Neurosurg Psychiatry 7:262–264Google Scholar
- 29.Billiau A (1996) Interferon–γ. Biology and role in pathogenesis. Adv Immunology 62:61–129Google Scholar
- 34.Griffin DE, Ward BJ, Jauregui E, Johnson RT, Vaisberg A (1990) Immune activation during measles: Interferon–γ and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J Inf Dis 161:449–453Google Scholar